ABSTRACT
The zoonotic enterohemorrhagic Escherichia coli (EHEC) O157: H7 bacterium causes diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome (HUS) in humans. Cattle are primary reservoirs and EHEC O157: H7; the bacteria predominately inhabit the colon and recto-anal junctions (RAJ). The early innate immune reactions in the infected gut are critical in the pathogenesis of EHEC O157: H7. In this study, calves orally inoculated with EHEC O157: H7 showed infiltration of neutrophils in the lamina propria of ileum and RAJ at 7 and 14 days post-infection. Infected calves had altered mucin layer and mast cell populations across small and large intestines. There were differential transcription expressions of key bovine ß defensins, tracheal antimicrobial peptide (TAP) in the ileum, and lingual antimicrobial peptide (LAP) in RAJ. The main Gram-negative bacterial/LPS signaling Toll-Like receptor 4 (TLR4) was downregulated in RAJ. Intestinal infection with EHEC O157: H7 impacted the gut bacterial communities and influenced the relative abundance of Negativibacillus and Erysipelotrichaceae in mucosa-associated bacteria in the rectum. Thus, innate immunity in the gut of calves showed unique characteristics during infection with EHEC O157: H7, which occurred in the absence of major clinical manifestations but denoted an active immunological niche.
Subject(s)
Escherichia coli Infections/immunology , Escherichia coli O157/metabolism , Gastrointestinal Microbiome/immunology , Adhesins, Bacterial/immunology , Animals , Cattle , Cattle Diseases/immunology , Diarrhea/microbiology , Escherichia coli O157/pathogenicity , Escherichia coli Proteins/immunology , Hemolytic-Uremic Syndrome/microbiology , Ileum/pathology , Rectum/microbiologyABSTRACT
Bovine leukemia virus (BLV) and human T-lymphotropic virus type 1 (HTLV-1) are closely related d-retroviruses that induce hematological diseases. HTLV-1 infects about 15 million people worldwide, mainly in subtropical areas. HTLV-1 induces a wide spectrum of diseases (e.g., HTLV-associated myelopathy/tropical spastic paraparesis) and leukemia/lymphoma (adult T-cell leukemia). Bovine leukemia virus is a major pathogen of cattle, causing important economic losses due to a reduction in production, export limitations and lymphoma-associated death. In the absence of satisfactory treatment for these diseases and besides the prevention of transmission, the best option to reduce the prevalence of d-retroviruses is vaccination. Here, we provide an overview of the different vaccination strategies in the BLV model and outline key parameters required for vaccine efficacy.
Subject(s)
Deltaretrovirus Infections/prevention & control , Deltaretrovirus/immunology , Vaccination , Viral Vaccines/immunology , Animals , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , Cattle , Deltaretrovirus/physiology , Deltaretrovirus Infections/virology , Enzootic Bovine Leukosis/prevention & control , Enzootic Bovine Leukosis/virology , HTLV-I Infections/prevention & control , Human T-lymphotropic virus 1/immunology , Human T-lymphotropic virus 1/physiology , Humans , Leukemia Virus, Bovine/immunology , Leukemia Virus, Bovine/physiology , Vaccines, Attenuated/immunologyABSTRACT
A Mycobacterium bovis strain deleted in mce2A and mce2B genes (M. bovis Δmce2) was tested as an experimental vaccine in cattle challenged with a virulent M. bovis strain. Three-and-a-half-month old calves (n = 5 to 6 per group) were vaccinated and challenged with a virulent strain of M. bovis by the intratracheal route 9 weeks after vaccination. A non-vaccinated group and a group vaccinated with BCG were included as controls. Blood samples were collected to measure IFN-γ by an interferon-gamma release assay (IGRA), cytometry and cytokine responses of bovine purified protein derivative (PPD) restimulated peripheral blood mononuclear cells (PBMCs). The IGRA test showed IFN-γ values similar to pre-vaccination except for the animals vaccinated with M. bovis Δmce2, where a significant increase was observed at 30 days post-vaccination. The expression of IL-2R on CD4(+) cells in response to PPD from the animals vaccinated with Δmce2 increased at 15 days post-vaccination compared to cells from non-vaccinated group. Vaccination of cattle with M. bovis Δmce2 induced the highest (P < 0.05) expression of IFN-γ and IL-17 mRNA upon PPD stimulation of PBMCs compared to vaccination with BCG or that for the non-vaccinated group. There was a weak positive correlation between the production of these proinflammatory cytokines post-vaccination and reduced pathology scores post-challenge. The animals were euthanized and necropsied 100 days after challenge. The group vaccinated with M. bovis Δmce2 displayed a significantly lower histopathological score for lesions in lungs and pulmonary lymph nodes than for the other groups (P < 0.05). A marked positive reaction to tuberculin intradermal test was observed post-vaccination in animals vaccinated with M. bovis Δmce2 compared to those vaccinated with BCG or the non-vaccinated group. In contrast, after challenge, non-vaccinated animals had greater skin test responses than the vaccinated animals. In summary, M. bovis Δmce2 is a promising vaccine candidate to control M. bovis pathogenesis in cattle.
Subject(s)
Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Mycobacterium bovis/genetics , Tuberculosis Vaccines/immunology , Tuberculosis, Bovine/prevention & control , Animals , Antigens, Bacterial/immunology , BCG Vaccine , Bacterial Load , Bacterial Proteins/immunology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cattle , Cytokines/biosynthesis , Cytokines/blood , Cytokines/genetics , Gene Deletion , Interferon-gamma/biosynthesis , Interferon-gamma Release Tests/methods , Lymphocyte Activation/immunology , Lymphocyte Subsets/immunology , Mycobacterium bovis/pathogenicity , Tuberculin/immunology , Tuberculin Test , Tuberculosis, Bovine/immunology , Tuberculosis, Bovine/microbiology , Tuberculosis, Bovine/pathology , Vaccines, Attenuated/immunology , VirulenceABSTRACT
Mycobacterium bovis is the causative agent of tuberculosis in cattle but also infects other animals, including humans. Previous studies in cattle have demonstrated that the protection induced by BCG is not complete. In order to improve the protection efficacy of BCG, in this study we overexpressed Ag85B in a BCG Pasteur strain, by using an expression system based on the use of an auxotrophic strain for the leucine amino acid, and complementation with leuD. We found that vaccination of cattle with BCG overexpressing Ag85B induced higher production of IL-17 and IL-4 mRNA upon purified protein derivative (PPDB) stimulation of peripheral blood mononuclear cells (PBMCs) than vaccination with BCG. Moreover, the IL-17 mRNA expression after vaccination negatively correlated with disease severity resulting from a subsequent challenge with M. bovis, suggesting that this cytokine is a potential biomarker of cattle protection against bovine tuberculosis. Importantly, vaccination with the recombinant BCG vaccine protected cattle better than the wild-type BCG Pasteur.
Subject(s)
BCG Vaccine/administration & dosage , Cattle Diseases/prevention & control , Mycobacterium bovis/immunology , Tuberculosis, Bovine/prevention & control , Animals , Cattle , Cattle Diseases/immunology , DNA Primers , Flow Cytometry , Interferon-gamma/biosynthesis , Polymerase Chain Reaction , Tuberculin Test , Tuberculosis, Bovine/immunologyABSTRACT
The generation of efficient candidate vaccines against bovine tuberculosis will contribute to the control of this zoonotic disease. Rationally attenuated Mycobacterium bovis strains generated by knockout of virulence genes are promising candidate vaccines. However, to be effective, these candidate vaccines should at least maintain the immunological properties of their virulent parental M. bovis strains. Therefore, the aim of this study was to obtain an M. bovis strain deleted in the mce2 genes and evaluate the effect of the mutation on the immunological profile elicited by the bacteria in cattle. We showed that the activation of CD4+ T cells in cattle inoculated with the mutant strain was equivalent to that in animals inoculated with the parental strain. Moreover, after in vitro stimulation, peripheral blood mononuclear cells from animals inoculated with the mutant produced higher levels of mRNA Th-1 cytokines than the parental strain. Therefore, these results indicate that the mce2 mutant is a promising candidate vaccine against bovine tuberculosis.
Subject(s)
Cattle/immunology , Mycobacterium bovis/genetics , Mycobacterium bovis/immunology , Tuberculosis Vaccines/genetics , Tuberculosis Vaccines/immunology , Tuberculosis, Bovine/immunology , Animals , Antigens, Bacterial/genetics , Bacterial Proteins/genetics , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cells, Cultured , Cytokines/genetics , Cytokines/immunology , Cytokines/metabolism , Gene Knockout Techniques , Host-Pathogen Interactions , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Polymerase Chain Reaction , RNA, Messenger/analysis , Tuberculosis Vaccines/administration & dosage , Tuberculosis, Bovine/prevention & controlABSTRACT
Bovine leukemia virus (BLV) is a retrovirus closely related to the human T-lymphotropic virus type 1 (HTLV-1). BLV is a major animal health problem worldwide causing important economic losses. A series of attempts were developed to reduce prevalence, chiefly by eradication of infected cattle, segregation of BLV-free animals and vaccination. Although having been instrumental in regions such as the EU, these strategies were unsuccessful elsewhere mainly due to economic costs, management restrictions and lack of an efficient vaccine. This review, which summarizes the different attempts previously developed to decrease seroprevalence of BLV, may be informative for management of HTLV-1 infection. We also propose a new approach based on competitive infection with virus deletants aiming at reducing proviral loads.
Subject(s)
Carrier State/prevention & control , Carrier State/veterinary , Enzootic Bovine Leukosis/prevention & control , HTLV-I Infections/prevention & control , Human T-lymphotropic virus 1/isolation & purification , Leukemia Virus, Bovine/isolation & purification , Animals , Carrier State/virology , Cattle , Enzootic Bovine Leukosis/virology , HTLV-I Infections/virology , HumansABSTRACT
BACKGROUND: In many regions of the world, wild mammals act as reservoir of Mycobacterium bovis, a situation that prevents the eradication of bovine tuberculosis. In order to observe whether a strain isolated from a wild boar, previously tested as highly virulent in a mice model, is also virulent in cattle, we performed cattle experimental inoculation with this strain RESULTS: Groups of Friesian calves were either infected with the wild boar strain M. bovis 04-303 or with the bovine strain NCTC10772 as a control. We found that antigen-specific IFN-γ release in whole blood samples occurred earlier in animals infected with M. bovis 04-303. Both M. bovis strains resulted in a positive skin test, with animals infected with the wild boar isolate showing a stronger response. These results and the presence of more severe organ lesions, with granuloma and pneumonic areas in cattle demonstrate that the wild boar isolate is more virulent than the NCTC10772 strain. Additionally, we tested the infectivity of the M. bovis strains in guinea pigs and found that M. bovis 04-303 had the highest pathogenicity. CONCLUSIONS: M. bovis strains isolated from wild boars may be pathogenic for cattle, producing TB lesions.
Subject(s)
Disease Reservoirs/veterinary , Mycobacterium bovis/immunology , Sus scrofa/microbiology , Tuberculosis, Bovine/microbiology , Animals , Argentina/epidemiology , Biological Assay/veterinary , Cattle , DNA Transposable Elements/genetics , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Disease Reservoirs/microbiology , Female , Guinea Pigs , Histocytochemistry/veterinary , Interferon-gamma/blood , Liver/microbiology , Lung/microbiology , Lymph Nodes/microbiology , Male , Mycobacterium bovis/genetics , Mycobacterium bovis/pathogenicity , Polymerase Chain Reaction/veterinary , Tuberculosis, Bovine/epidemiology , Tuberculosis, Bovine/immunology , Tuberculosis, Bovine/transmission , VirulenceABSTRACT
The identification of bovine tuberculosis (bTB) biomarkers in specific stages of the disease will contribute to a better understanding of the immunopathology associated with tuberculosis and to improve the disease diagnosis and prognosis. The aim of this study was to understand the changing profile of the immune responses during the course of infection and to identify biomarkers associated with pathology. Here we describe the immune response developed in experimentally infected cattle with field Mycobacterium bovis strains. Blood samples were taken from each animal at different time points after M. bovis intratracheal infection and lymphocyte subset activation and cytokine mRNA expression were determined from peripheral blood mononuclear cells in response to purified protein derivative (PPDB). We found that CD4 and CD8 activation during the early stages of infection, together with IL-17 gene expression, were positively associated with pathology. The results of this study provide evidences of the role of IL-17 in the immunopathology of tuberculosis and support the use of IL-17 as a potential biomarker with predictive value of prognosis in bTB.